These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 8996531)
1. Continuous intratumoral microdialysis during high-dose methotrexate therapy in a patient with malignant fibrous histiocytoma of the femur: a case report. Ekstrøm PO; Andersen A; Saeter G; Giercksky KE; Slørdal L Cancer Chemother Pharmacol; 1997; 39(3):267-72. PubMed ID: 8996531 [TBL] [Abstract][Full Text] [Related]
2. Determination of extracellular methotrexate tissue levels by microdialysis in a rat model. Ekstrøm PO; Andersen A; Warren DJ; Giercksky KE; Slørdal L Cancer Chemother Pharmacol; 1996; 37(5):394-400. PubMed ID: 8599860 [TBL] [Abstract][Full Text] [Related]
3. Alterations in methotrexate pharmacokinetics by naproxen in the rat as measured by microdialysis. Ekstrøm PO; Giercksky KE; Andersen A; Slørdal L Life Sci; 1997; 60(24):PL 359-64. PubMed ID: 9188769 [TBL] [Abstract][Full Text] [Related]
4. The value of high-dose methotrexate-based neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone. Ham SJ; Hoekstra HJ; van der Graaf WT; Kamps WA; Molenaar WM; Schraffordt Koops H J Clin Oncol; 1996 Feb; 14(2):490-6. PubMed ID: 8636762 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of methotrexate tissue exposure by in situ microdialysis in a rat model. Ekstrøm O; Andersen A; Warren DJ; Giercksky KE; Slørdal L Cancer Chemother Pharmacol; 1994; 34(4):297-301. PubMed ID: 8033296 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of different doses of methotrexate at steady state by in situ microdialysis in a rat model. Ekstrøm PO; Anderson A; Warren DJ; Giercksky KE; Slørdal L Cancer Chemother Pharmacol; 1995; 36(4):283-9. PubMed ID: 7628046 [TBL] [Abstract][Full Text] [Related]
7. Determination of free extracellular levels of methotrexate by microdialysis in muscle and solid tumor of the rabbit. Dukic S; Kaltenbach ML; Gourdier B; Marty H; Vistelle R Pharm Res; 1998 Jan; 15(1):133-8. PubMed ID: 9487560 [TBL] [Abstract][Full Text] [Related]
8. In vivo microdialysis to characterize drug transport in brain tumors: analysis of methotrexate uptake in rat glioma-2 (RG-2)-bearing rats. Devineni D; Klein-Szanto A; Gallo JM Cancer Chemother Pharmacol; 1996; 38(6):499-507. PubMed ID: 8823490 [TBL] [Abstract][Full Text] [Related]
9. Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study. Blakeley JO; Olson J; Grossman SA; He X; Weingart J; Supko JG; J Neurooncol; 2009 Jan; 91(1):51-8. PubMed ID: 18787762 [TBL] [Abstract][Full Text] [Related]
10. The effects of drug transporter inhibitors on the pharmacokinetics and tissue distribution of methotrexate in normal and tumor-bearing mice: a microdialysis study. Sani SN; Henry K; Böhlke M; Kim J; Stricker-Krongrad A; Maher TJ Cancer Chemother Pharmacol; 2010 May; 66(1):159-69. PubMed ID: 19816684 [TBL] [Abstract][Full Text] [Related]
11. Interstitial methotrexate kinetics in primary breast cancer lesions. Müller M; Brunner M; Schmid R; Mader RM; Bockenheimer J; Steger GG; Steiner B; Eichler HG; Blöchl-Daum B Cancer Res; 1998 Jul; 58(14):2982-5. PubMed ID: 9679959 [TBL] [Abstract][Full Text] [Related]
12. Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia. Csordas K; Hegyi M; Eipel OT; Muller J; Erdelyi DJ; Kovacs GT Anticancer Drugs; 2013 Feb; 24(2):189-97. PubMed ID: 23187460 [TBL] [Abstract][Full Text] [Related]
13. High-dose methotrexate in children with acute lymphoblastic leukemia: 7-hydroxymethotrexate systemic exposure and urinary concentrations at the steady state correlate well with those of methotrexate. Chládková J; Hak J; Martínková J; Chládek J Arzneimittelforschung; 2010; 60(12):769-75. PubMed ID: 21265469 [TBL] [Abstract][Full Text] [Related]
14. [Investigation on individualized adjustment of target range of high-dose methotrexate]. Hua Y; Zhao WH; Lu XT; Yang LH; Lu W Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):203-8. PubMed ID: 19099710 [TBL] [Abstract][Full Text] [Related]
15. Determination of methotrexate and its major metabolite 7-hydroxymethotrexate in mouse plasma and brain tissue by liquid chromatography-tandem mass spectrometry. Guo P; Wang X; Liu L; Belinsky MG; Kruh GD; Gallo JM J Pharm Biomed Anal; 2007 Apr; 43(5):1789-95. PubMed ID: 17289326 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of methotrexate in the extracellular fluid of brain C6-glioma after intravenous infusion in rats. Dukic S; Heurtaux T; Kaltenbach ML; Hoizey G; Lallemand A; Gourdier B; Vistelle R Pharm Res; 1999 Aug; 16(8):1219-25. PubMed ID: 10468023 [TBL] [Abstract][Full Text] [Related]
17. Intratumoral differences in methotrexate levels within human osteosarcoma xenografts studied by microdialysis. Ekstrøm PO; Giercksky KE; Andersen A; Bruland OS; Slørdal L Life Sci; 1997; 61(19):PL275-80. PubMed ID: 9364204 [TBL] [Abstract][Full Text] [Related]
18. Development of a dog microdialysis model for determining synovial fluid pharmacokinetics of anti-arthritis compounds exemplified by methotrexate. Qian M; West W; Wu JT; Lu B; Christ DD Pharm Res; 2003 Apr; 20(4):605-10. PubMed ID: 12739768 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic individualization of high-dose methotrexate chemotherapy for the treatment of localized osteosarcoma. Fujita Y; Nakamura T; Aomori T; Nishiba H; Shinozaki H; Yanagawa T; Takagishi K; Watanabe H; Okada Y; Nakamura K; Horiuchi R; Yamamoto K J Chemother; 2010 Jun; 22(3):186-90. PubMed ID: 20566424 [TBL] [Abstract][Full Text] [Related]
20. High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma. Crews KR; Liu T; Rodriguez-Galindo C; Tan M; Meyer WH; Panetta JC; Link MP; Daw NC Cancer; 2004 Apr; 100(8):1724-33. PubMed ID: 15073863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]